QMED PHARMACEUTICALS LTDActive

Company number 09572820Private limited companyIncorporated 2015
⚠ Confirmation statement overdue. It was due on 17 Oct 2026.

Key figures

£2,474,073+30.5%
Net assets 2024/25
+91.8%
Average annual growth 2019/20–2024/25
01 m2 m3 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, QMED PHARMACEUTICALS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Profit for the year—344,523———
Cash at bank and in hand—177,6881,147,9791,486,302712,830
Total assets815,9391,040,9742,520,2543,253,6633,895,205
Total liabilities562,116687,5901,227,676——
Net assets / total equity253,823468,3451,399,1611,895,6792,474,073
Average number of employees1721332635

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: QMED PHARMACEUTICALS LTD

Company

QMED PHARMACEUTICALS LTD is a private limited company registered with Companies House under company number 09572820. It was incorporated on 5 May 2015. Its status is active. The registered office is in Seven kings (IG3). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £2,474,073, up 30.5% on the previous year. Cash at bank and in hand was £712,830. The company had an average of 35 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

3 persons with significant control are registered.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 17 Oct 2026.